The Venture Codex Logo

The Venture Codex

Overview

Technology breakthroughs in oncology for patient health improvement.

Founded

2012

Deals ยท 12mo

0

Stage focus

Series B
Series C

Geographic focus

South Korea
United States

Sector focus

Biotechnology
Health Care
Health Diagnostics
Oncology
...

Investment portfolio

4rounds
NAMEDATESIZE
ObvioHealth
Jul 2024Led
$18 MSeries B
Lunit
Nov 2021Participated
$61 MOther Equity
Lunit
Aug 2021Led
$26 MSeries C
Guardant Health
May 2017Participated
$360 MOther Equity
ObvioHealth
Jul 2024Led
$18 MSeries B
Lunit
Nov 2021Participated
$61 MOther Equity
Lunit
Aug 2021Led
$26 MSeries C
Guardant Health
May 2017Participated
$360 MOther Equity
4
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Guardant Health: 4 funding rounds are recorded in the selected participation categories.All available history.
Guardant Health: 4 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series B10
Series C+10
Other Equity02

Monthly Deal Activity

Guardant Health: 4 deals are recorded across 114 months.All available history.
Guardant Health: 4 deals are recorded across 114 months. All available history
MonthDeals
May '171
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '211
Sep '210
Oct '210
Nov '211
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '241
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Guardant Health: Health & Life Sciences is the largest displayed sector by deal count (4 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Guardant Health: Health & Life Sciences is the largest displayed sector by deal count (4 deals). All available history
SectorDeals
Health & Life Sciences4
Enterprise Software2
AI & Machine Learning2

Deal Size Distribution

Guardant Health: 4 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Guardant Health: 4 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M1
$50M-$100M1
$100M-$250M0
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

Guardant Health: United States has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Guardant Health: United States has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
United States2
South Korea2
Guardant Health: 18 co-investors are shown, with 8VC sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Guardant Health: Led accounts for 50% and participating for 50% of round participation.All available history.
Guardant Health: Led accounts for 50% and participating for 50% of round participation. All available history
CategoryDeals (count)Share (%)
Led250%
Participating250%
Guardant Health: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Guardant Health: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead150%
Co-led150%

Team

AmirAli Talasaz

Co-founder and Co-CEO

Darya Chudova

Senior Vice President of Technology

Greg Schafer

Senior Director Market Access

Helmy Eltoukhy

Co-founder & CEO

Kumud Kalia

Chief Information Officer

Mark Lubarsky

Lead Software Engineer, Manager

Naveen Kumar

Head, GuardantINFORM

Oliver Rocroi

Senior Director, U.S. Government Affairs

William Biggs

Sr. Director & Site Head